OSCR - Oscar Health, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $34.75 DETAILS

Stock News

Best Growth Stocks to Buy for October 13th

WOOF, FIVE, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13, 2026.

Oct 13, 2026 03:15 AM • zacks.com

Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call

NEW YORK--(BUSINESS WIRE)--Oscar Health will release its third quarter 2026 financial results on Thursday, November 5, 2026.

Oct 12, 2026 04:01 AM • businesswire.com

Best Growth Stocks to Buy for October 9th

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 9th, 2026.

Oct 09, 2026 02:46 AM • zacks.com

Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?

Oscar Health's ACA marketplace expansion fuels growth prospects, but subsidy uncertainty, rising medical costs and pricing risks could challenge lasting profits.

Oct 08, 2026 10:05 AM • zacks.com

Oscar Health, Inc. (OSCR) Advances While Market Declines: Some Information for Investors

Oscar Health, Inc. (OSCR) reached $32.91 at the closing of the latest trading day, reflecting a +1.76% change compared to its last close.

Oct 07, 2026 03:15 PM • zacks.com

Zacks Industry Outlook Prudential Financial, Assurant, Oscar and Horace Mann

Prudential Financial, Assurant, Oscar and Horace Mann have been highlighted in this Industry Outlook article.

Oct 07, 2026 01:25 AM • zacks.com

Best Growth Stocks to Buy for October 7th

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 7th, 2026.

Oct 07, 2026 12:11 AM • zacks.com

5 Stocks to Buy From the Prosperous Multiline Insurance Industry

Better pricing, product redesigns and technological advancements are expected to aid Zacks Multiline Insurance industry players like PRU, PFG, AIZ, OSCR and HMN.

Oct 06, 2026 10:46 AM • zacks.com

Is Oscar Health Inc (OSCR) Overvalued After 4.8% Rally? GF Value Says Overvalued

Valuation Assessment of Oscar Health Inc (OSCR)On October 05, 2026, Oscar Health Inc (OSCR) shares rose 4.8% to $32.42, marking a significant year-to-date incre

Oct 05, 2026 02:49 PM • gurufocus.com

Oscar Health Trading at a Premium: Why Should You Still Buy It?

Oscar Health's premium valuation reflects surging membership, improving profitability, a scalable tech platform and growth targets through 2027.

Oct 05, 2026 11:40 AM • zacks.com

Best Growth Stocks to Buy for October 5th

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 5th, 2026.

Oct 05, 2026 12:10 AM • zacks.com

Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts

Oscar Health, Inc. (OSCR) reached $29.9 at the closing of the latest trading day, reflecting a -3.05% change compared to its last close.

Oct 01, 2026 03:01 PM • zacks.com

3 Healthcare Stocks Showing Why the Sector Still Has Momentum

The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.

Sep 28, 2026 07:32 AM • marketbeat.com

Oscar Health: Market Share Gains Are Only Part Of The Plan

Oscar Health is rated a buy, targeting a $45-$49 fair value, driven by scalable growth and margin expansion in the ACA market. OSCR grew membership 60% while the overall ACA market contracted 13%, achieving a 30% market share and improving the medical loss ratio to 81.5%. Management guides for 2029 revenue CAGR above 20%, a 5-7% operating margin, and $4+ EPS, with the Lucie marketplace as a key incremental driver.

Sep 26, 2026 05:31 PM • seekingalpha.com

Best Growth Stocks to Buy for September 25th

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 25th, 2026.

Sep 25, 2026 01:45 AM • zacks.com

Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?

Oscar Health's profit rebound faces a test as rising medical spending and a larger member base threaten second-half profitability.

Sep 23, 2026 11:01 AM • zacks.com

All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy

Oscar Health (OSCR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Sep 23, 2026 09:01 AM • zacks.com

Best Momentum Stocks to Buy for September 23rd

OSCR, SNDR and TFII made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 23rd, 2026.

Sep 23, 2026 07:00 AM • zacks.com

Oscar Health: Investor Day Offered New TAM Forecast Which Is Very Bullish, If Smoothly Executed

Oscar Health is upgraded to Strong Buy with a new $45 fair value, reflecting raised 2026–2029 earnings targets and an expanded TAM. Management projects 2029 EPS of $4+ and 2026 operating earnings of $600–800M, driven by ACA execution, CHOICE, and Lucie marketplace growth. CHOICE and Lucie expand OSCR's addressable market by 65%, with revenue estimates rising from $18.85B in 2026 to $32.6B in 2029.

Sep 23, 2026 04:26 AM • seekingalpha.com